Showing results (151-160 of 426) with videos related to
Sort By:
Pageof 43
Neuroimmunomodulation|August 22, 2007
Stress as a risk factor in the pathogenesis of rheumatoid arthritisMaurizio Cutolo, Rainer H StraubAutoimmunity Reviews|January 15, 2008
Circadian rhythms in arthritis: hormonal effects on the immune/inflammatory reactionMaurizio Cutolo, Rainer H StraubRheumatology (Oxford, England)|November 19, 2016
Glucocorticoids and chronic inflammationRainer H Straub, Maurizio CutoloRheumatic Diseases Clinics of North America|January 11, 2005
Circadian rhythms and arthritisMaurizio Cutolo, Alfonse T MasiClinical Rheumatology|July 21, 2025
Nailfold videocapillaroscopy in juvenile dermatomyositis: detailed correlations between microvascular abnormalities with clinical and laboratory parameters from an observational retrospective single-center studyPietro Francesco Bica, Elvis Hysa, Rosanna Campitiello, et al.Nutrients|October 20, 2020
Beverages in Rheumatoid Arthritis: What to Prefer or to AvoidMrinalini Dey, Maurizio Cutolo, Elena NikiphorouReumatologia|October 24, 2017
Glucocorticoid management in rheumatoid arthritis: morning or night low dose?Sabrina Paolino, Maurizio Cutolo, Carmen PizzorniRheumatology (Oxford, England)|February 13, 2013
Efficacy and safety of leflunomide in DMARD-naive patients with early rheumatoid arthritis: comparison of a loading and a fixed-dose regimenMaurizio Cutolo, Horatiu Bolosiu, Gilles Perdriset, et al.Neuroimmunomodulation|September 18, 2014
The past versus the present, 1980-2004: reduction of mean initial low-dose, long-term glucocorticoid therapy in rheumatoid arthritis from 10.3 to 3.6 mg/day, concomitant with early methotrexate, with long-term effectiveness and safety of less than 5 mg/dayTheodore Pincus, Tuulikki Sokka, Maurizio CutoloClinical and Experimental Rheumatology|December 21, 2012
1,25-dihydroxyvitamin D3 downregulates aromatase expression and inflammatory cytokines in human macrophagesBarbara Villaggio, Stefano Soldano, Maurizio CutoloPageof 43